Page last updated: 2024-08-24

capecitabine and Cancer of Duodenum

capecitabine has been researched along with Cancer of Duodenum in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (66.67)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Amano, T; Araki, M; Egawa, S; Hayashi, Y; Hirao, M; Hiyama, S; Iijima, H; Inoue, T; Iwatani, S; Kinoshita, K; Kizu, T; Komori, M; Mizushima, T; Morii, E; Murata, J; Nagaike, K; Ogawa, H; Okuda, Y; Otake, Y; Sakakibara, Y; Shinzaki, S; Sugimoto, A; Takahashi, H; Takehara, T; Tani, M; Tashiro, T; Tsujii, Y; Yamaguchi, S; Yoshihara, T1
Ichikawa, H; Ishikawa, H; Kano, Y; Kobayashi, T; Miura, K; Muneoka, Y; Nakano, M; Sakata, J; Shimada, Y; Tajima, Y; Takizawa, K; Toshikawa, C; Ueki, H; Wakai, T1
Cunningham, SC; Gormley, PE; Iacobuzio-Donahue, CA; Kern, SE; Patel, K1
Bai, L; Guo, XC; Mao, ZY; Su, D; Wang, LJ; Zhang, TT1
Kirii, Y; Miyamoto, M; Takagi, H1
Jadhav, P; Rogers, JE; Shroff, R1

Other Studies

6 other study(ies) available for capecitabine and Cancer of Duodenum

ArticleYear
Vascular endothelial growth factor-A is an Immunohistochemical biomarker for the efficacy of bevacizumab-containing chemotherapy for duodenal and jejunal adenocarcinoma.
    BMC cancer, 2021, Aug-31, Volume: 21, Issue:1

    Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biomarkers, Tumor; Capecitabine; Duodenal Neoplasms; Female; Follow-Up Studies; Humans; Immunohistochemistry; Jejunal Neoplasms; Leucovorin; Male; Organoplatinum Compounds; Prognosis; Retrospective Studies; Survival Rate; Vascular Endothelial Growth Factor A

2021
[A Case of Long-Term Survival with Multidisciplinary Treatment after Surgery for Duodenal Cancer with Left Supraclavicular Lymph Node Metastasis].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2022, Volume: 49, Issue:13

    Topics: Aged; Capecitabine; Duodenal Neoplasms; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Oxaliplatin; Positron Emission Tomography Computed Tomography

2022
Are we systematically under-dosing patients with fluorouracil?
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, Mar-01, Volume: 33, Issue:7

    Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Capecitabine; Chemotherapy, Adjuvant; Deoxycytidine; Drug Administration Schedule; Duodenal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Neoadjuvant Therapy; Pancreatic Neoplasms; Pancreaticoduodenectomy

2015
Retrospective analysis of 119 small bowel adenocarcinoma in Chinese patients.
    Cancer investigation, 2014, Volume: 32, Issue:5

    Topics: Abdominal Pain; Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; CA-19-9 Antigen; Capecitabine; Carcinoembryonic Antigen; Chemotherapy, Adjuvant; China; Deoxycytidine; Disease-Free Survival; Duodenal Neoplasms; Duodenum; Female; Fluorouracil; Humans; Leucovorin; Lymphatic Metastasis; Male; Middle Aged; Organoplatinum Compounds; Oxaloacetates; Palliative Care; Retrospective Studies; Survival Rate; Treatment Outcome

2014
[A case of primary duodenal cancer recurrence successfully treated with CapeOX therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:4

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Duodenal Neoplasms; Fatal Outcome; Fluorouracil; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Pancreaticoduodenectomy; Peritoneal Neoplasms; Recurrence

2014
A Case Report-Stevens-Johnson Syndrome as an Adverse Effect of Capecitabine.
    Journal of gastrointestinal cancer, 2018, Volume: 49, Issue:3

    Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Capecitabine; Duodenal Neoplasms; Humans; Male; Middle Aged; Pancreatic Neoplasms; Stevens-Johnson Syndrome

2018